Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CARGo carbamazepine study for uncomplicated gonorrhoea in women
ACTRN12624000420549Phase 3Recruiting
- Sponsor
- Griffith University
- Start
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of carbamazepine in gonorrhea, gonococcal infection of the cervix, Gonococcal pharyngitis and 1 more, sponsored by Griffith University. Primary endpoints: Efficacy in cervical gonorrhoea infection and Disruption of gonococcal interaction with cervical epithelial cells. Started Aug 2025; status: recruiting.
02
Drugs
carbamazepine
03
Conditions
gonorrheagonococcal infection of the cervixGonococcal pharyngitisgonococcal proctitis
Beyond the preview
Go deeper on ACTRN12624000420549.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12624000420549.